These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
3. Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation. Russo AM; Chung MK Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):337-46. PubMed ID: 24736423 [No Abstract] [Full Text] [Related]
6. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project. Stefano B; Pietro RR; Maurizio G; Maurizio L; Renato M; Maurizio L; Pietro R; Alessandro P; Gianluca B; Monica M; Sergio C; Massimo S Am Heart J; 2011 Aug; 162(2):390-7. PubMed ID: 21835302 [TBL] [Abstract][Full Text] [Related]
7. Management of high defibrillation threshold. Uyguanco ER; Berger A; Budzikowski AS; Gunsburg M; Kassotis J Expert Rev Cardiovasc Ther; 2008 Oct; 6(9):1237-48. PubMed ID: 18939911 [TBL] [Abstract][Full Text] [Related]
9. Implantable Cardioverter Defibrillator Implantation with or Without Defibrillation Testing. Duffett S; El Hajjaji I; Manlucu J; Yee R Card Electrophysiol Clin; 2018 Mar; 10(1):119-125. PubMed ID: 29428133 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
11. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion. Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316 [TBL] [Abstract][Full Text] [Related]
12. Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry. Arnson Y; Suleiman M; Glikson M; Sela R; Geist M; Amit G; Schliamser JE; Goldenberg I; Ben-Zvi S; Orvin K; Rosenheck S; Adam Freedberg N; Strasberg B; Haim M Heart Rhythm; 2014 May; 11(5):814-21. PubMed ID: 24486799 [TBL] [Abstract][Full Text] [Related]
13. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577 [TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
15. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation? Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing]. Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404 [TBL] [Abstract][Full Text] [Related]
17. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Russo AM; Sauer W; Gerstenfeld EP; Hsia HH; Lin D; Cooper JM; Dixit S; Verdino RJ; Nayak HM; Callans DJ; Patel V; Marchlinski FE Heart Rhythm; 2005 May; 2(5):456-61. PubMed ID: 15840466 [TBL] [Abstract][Full Text] [Related]
18. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]